Download | < Back |
04 Aug 2022 | |
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith summary of proceedings of 43rd Annual General Meeting of the Company held on 4th August 2022 through Video- conference/Other Audio-Visual Means. | |
View all announcements for AJANTA PHARMA LTD. | Source: BSE India |